Latest Insider Transactions at Amarin Corp Plcuk (AMRN)
This section provides a real-time view of insider transactions for Amarin Corp Plcuk (AMRN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AMARIN CORP PLCUK to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AMARIN CORP PLCUK's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 25
2021
|
John F Thero President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
153,739
-4.7%
|
$1,076,173
$7.3 P/Share
|
|
Feb 25
2021
|
John F Thero President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
390,696
+10.67%
|
-
|
|
Feb 25
2021
|
Joseph T Kennedy General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
55,140
-15.99%
|
$385,980
$7.3 P/Share
|
|
Feb 25
2021
|
Joseph T Kennedy General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
104,728
+23.3%
|
-
|
|
Feb 25
2021
|
Steven B Ketchum Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
45,327
-9.61%
|
$317,289
$7.3 P/Share
|
|
Feb 25
2021
|
Steven B Ketchum Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
88,614
+15.82%
|
-
|
|
Feb 25
2021
|
Michael Wayne Kalb SVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
43,395
-19.82%
|
$303,765
$7.3 P/Share
|
|
Feb 25
2021
|
Michael Wayne Kalb SVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
88,614
+28.81%
|
-
|
|
Feb 25
2021
|
Aaron Berg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
43,638
-13.82%
|
$305,466
$7.3 P/Share
|
|
Feb 25
2021
|
Aaron Berg President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
88,614
+21.92%
|
-
|
|
Feb 01
2021
|
Steven B Ketchum Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
217,728
-19.12%
|
$1,741,824
$8.05 P/Share
|
|
Feb 01
2021
|
Steven B Ketchum Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
192,358
+9.14%
|
$384,716
$2.65 P/Share
|
|
Jan 29
2021
|
John F Thero President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
82,762
-1.4%
|
$579,334
$7.5 P/Share
|
|
Jan 29
2021
|
John F Thero President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
209,171
+1.74%
|
-
|
|
Jan 29
2021
|
Joseph T Kennedy General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
16,711
-3.31%
|
$116,977
$7.5 P/Share
|
|
Jan 29
2021
|
Joseph T Kennedy General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
42,345
+4.01%
|
-
|
|
Jan 29
2021
|
Michael Wayne Kalb SVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,928
-5.28%
|
$104,496
$7.5 P/Share
|
|
Jan 29
2021
|
Michael Wayne Kalb SVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
41,789
+6.81%
|
-
|
|
Jan 29
2021
|
Aaron Berg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,281
-1.37%
|
$43,967
$7.5 P/Share
|
|
Jan 29
2021
|
Aaron Berg President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,789
+2.19%
|
-
|
|
Jan 29
2021
|
Steven B Ketchum Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
21,535
-2.53%
|
$150,745
$7.5 P/Share
|
|
Jan 29
2021
|
Steven B Ketchum Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,789
+2.39%
|
-
|
|
Jan 27
2021
|
Steven B Ketchum Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
421,629
-30.67%
|
$3,373,032
$8.01 P/Share
|
|
Jan 27
2021
|
Steven B Ketchum Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
278,237
+4.75%
|
$556,474
$2.4 P/Share
|
|
Dec 31
2020
|
John F Thero President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,302
-0.19%
|
$26,510
$5.23 P/Share
|
|
Dec 31
2020
|
John F Thero President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,472
+0.24%
|
-
|
|
Dec 31
2020
|
Joseph T Kennedy General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,902
-0.88%
|
$9,510
$5.23 P/Share
|
|
Dec 31
2020
|
Joseph T Kennedy General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,612
+0.83%
|
-
|
|
Dec 31
2020
|
Steven B Ketchum Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,506
-0.28%
|
$7,530
$5.23 P/Share
|
|
Dec 31
2020
|
Steven B Ketchum Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,056
+0.29%
|
-
|
|
Dec 31
2020
|
Michael Wayne Kalb SVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,498
-1.43%
|
$7,490
$5.23 P/Share
|
|
Dec 31
2020
|
Michael Wayne Kalb SVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,056
+1.45%
|
-
|
|
Dec 31
2020
|
Aaron Berg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,506
-0.69%
|
$7,530
$5.23 P/Share
|
|
Dec 31
2020
|
Aaron Berg President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,056
+0.7%
|
-
|
|
Nov 30
2020
|
John F Thero President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,302
-0.19%
|
$21,208
$4.6 P/Share
|
|
Nov 30
2020
|
John F Thero President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,472
+0.24%
|
-
|
|
Nov 30
2020
|
Joseph T Kennedy General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,902
-0.89%
|
$7,608
$4.6 P/Share
|
|
Nov 30
2020
|
Joseph T Kennedy General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,612
+0.84%
|
-
|
|
Nov 30
2020
|
Steven B Ketchum Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,506
-0.28%
|
$6,024
$4.6 P/Share
|
|
Nov 30
2020
|
Steven B Ketchum Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,056
+0.29%
|
-
|
|
Nov 30
2020
|
Michael Wayne Kalb SVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,498
-1.45%
|
$5,992
$4.6 P/Share
|
|
Nov 30
2020
|
Michael Wayne Kalb SVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,056
+1.47%
|
-
|
|
Nov 30
2020
|
David M Stack |
BUY
Open market or private purchase
|
Indirect |
25,000
+50.0%
|
$100,000
$4.86 P/Share
|
|
Nov 30
2020
|
Aaron Berg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,506
-0.69%
|
$6,024
$4.6 P/Share
|
|
Nov 30
2020
|
Aaron Berg President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,056
+0.7%
|
-
|
|
Nov 11
2020
|
John F Thero President and CEO |
SELL
Open market or private sale
|
Direct |
413,565
-13.12%
|
$1,654,260
$4.07 P/Share
|
|
Nov 10
2020
|
John F Thero President and CEO |
SELL
Open market or private sale
|
Direct |
153,840
-4.65%
|
$615,360
$4.13 P/Share
|
|
Nov 10
2020
|
John F Thero President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
615,261
+15.69%
|
$1,845,783
$3.4 P/Share
|
|
Nov 09
2020
|
John F Thero President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
134,739
+4.77%
|
$404,217
$3.4 P/Share
|
|
Oct 30
2020
|
John F Thero President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,472
+0.26%
|
-
|